HRT Financial’s GSK GSK Stock Holding History

HRT Financial’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$31.7M	Buy	603,902 +178,215	+42%	+$9.43M	0.06%	308
2026 Q1	$23.5M	Buy	425,687 +129,940	+44%	+$7.04M	0.06%	297
2025 Q4	$14.5M	Buy	+295,747	New	+$13.8M	0.05%	315
2025 Q3	–	Sell	-31,370	Closed	-$1.2M	–	3171
2025 Q2	$1.2M	Buy	+31,370	New	+$1.2M	0.01%	1177
2024 Q4	–	Sell	-110,739	Closed	-$4.53M	–	2708
2024 Q3	$4.53M	Buy	+110,739	New	+$4.53M	0.02%	502
2024 Q2	–	Sell	-180,021	Closed	-$7.72M	–	2542
2024 Q1	$7.72M	Sell	180,021 -336,563	-65%	-$13.9M	0.05%	179
2023 Q4	$19.1M	Buy	516,584 +498,066	+2,690%	+$17.9M	0.14%	79
2023 Q3	$671K	Buy	+18,518	New	+$657K	0.01%	1234
2022 Q4	–	Sell	-85,793	Closed	-$2.52M	–	2724
2022 Q3	$2.52M	Buy	85,793 +73,983	+626%	+$2.8M	0.03%	523
2022 Q2	$642K	Buy	11,810 +16	+0.1%	+$883	0.01%	1308
2022 Q1	$642K	Buy	+11,794	New	+$641K	﹤0.01%	1447
2021 Q2	–	Sell	-58,177	Closed	-$2.6M	–	3106
2021 Q1	$2.6M	Buy	+58,177	New	+$2.64M	0.03%	487
2019 Q2	–	Sell	-4,332	Closed	-$226K	–	811
2019 Q1	$226K	Buy	+4,332	New	+$216K	0.04%	359
2018 Q4	–	Sell	-4,661	Closed	-$234K	–	659
2018 Q3	$234K	Buy	+4,661	New	+$237K	0.04%	301
2017 Q2	–	Sell	-3,806	Closed	-$200K	–	100
2017 Q1	$200K	Buy	+3,806	New	+$193K	0.19%	95

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

HRT Financial's GSK Position: Q2 2026 in Review

HRT Financial increased its GSK (GSK) stake by 42% in Q2 2026, buying an estimated $9.43M and bringing the position to 603,902 shares worth $31.7M. The position accounts for 0.06% of the portfolio, ranked #308.

HRT Financial first reported a position in GSK in Q1 2017 and has held it in 15 quarters since. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

HRT Financial held 603,902 shares of GSK worth $31.7M as of Q2 2026.
HRT Financial bought 178,215 GSK shares in Q2 2026, an estimated $9.43M.
GSK made up 0.06% of HRT Financial's portfolio in Q2 2026, its #308 holding.
HRT Financial first reported a position in GSK in Q1 2017 and has held it in 15 quarters since.
1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.